Protective effect of erythropoietin on inflammation of renal ischemia-reperfusion injury in rats

You-you WANG,Ning JIA,Li PENG,Hui-tao ZHANG,Ye ZHU,Jing ZHENG,Wei-ping ZHU,Hua ZHANG
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2013.19.043
2013-01-01
Abstract:Objective To investigate protective effects and mechanisms of erythropoietin(EPO) on inflammation induced by renal ischemia-reperfusion injury(IRI) in rats. Methods A total of 36 male Sprague-Dawley rats were randomly divided into 3 groups of Sham operation(SOR), IRI and EPO pretreatment(n=12 in each group). Renal IRI model was created by clamping the bilateral renal pedicle for 45 min and then released. 3000 IU/kg of EPO was administered in EPO group via the abdominal cavity 24 hours before clamping. Blood samples and the kidney were obtained at 2, 6, 12 and 24 h after reperfusion. The serous concentrations of blood urea nitrogen and serum creatinine were measured.The levels of tumor necrosis factor α(TNF-α) in the renal tissues were detected by ELISA, and the expression of phosphorylating-p38 mitogen-activated protein kinase(p-p38MAPK) in the renal tissues were assessed by western blot analyses. Results Compared with IRI group, the EPO treated group exhibited lower serum urea and creatinine levels(P0.05) and limited the renal histopathological lesion. The concentration of TNF-α and the expression of p-p38MAPK in renal tissue were greatly increased by IRI, but significantly reduced by the treatment of EPO. Conclusion EPO can attenuate the renal injury and dysfunction caused by IRI via reducing the expression of p-p38MAPK and the production of TNF-α. The renoprotective effect of EPO might be mediated by its inhibition of inflammation.
What problem does this paper attempt to address?